Pyrroloquinoline quinone—better known as PQQ—has gained significant attention in the nootropics community, largely due to claims that it stimulates nerve growth factor (NGF) production. NGF is a critical protein for neuron survival and plasticity, so any compound that genuinely enhances its production would be of considerable interest for cognitive health.
But supplement marketing often outpaces the science. Here, we examine what research actually demonstrates about PQQ and nerve growth factor, separating mechanistic plausibility from clinical evidence.
What Is Nerve Growth Factor and Why Does It Matter?
Nerve growth factor belongs to a family of proteins called neurotrophins. Discovered in the 1950s by Rita Levi-Montalcini—work that earned her a Nobel Prize—NGF plays essential roles in neuronal development, maintenance, and survival. In adult brains, NGF supports cholinergic neurons in the basal forebrain, a region critically involved in memory and attention.
Declining NGF levels have been associated with neurodegenerative conditions, particularly Alzheimer's disease. This has made NGF enhancement an attractive therapeutic target, though delivering NGF to the brain remains technically challenging due to its inability to cross the blood-brain barrier effectively.
The appeal of compounds that might stimulate endogenous NGF production—rather than requiring direct delivery—explains much of the interest in PQQ.
The Cell Culture Evidence
The foundation of PQQ's NGF reputation rests primarily on in vitro studies. A 1993 study published in Bioscience, Biotechnology, and Biochemistry by Yamaguchi et al. demonstrated that PQQ stimulated NGF synthesis in mouse astroglial cells. The effect was dose-dependent and appeared to work through mechanisms distinct from other known NGF stimulators.
Follow-up research by Murase et al. in 1993 showed that PQQ could enhance NGF-induced neurite outgrowth in PC12 cells—a standard model for studying neuronal differentiation. These findings suggested PQQ might both increase NGF production and potentiate its effects.
Key Cell Culture Findings
- PQQ stimulated NGF synthesis in astroglial cells in a dose-dependent manner
- Enhanced neurite outgrowth when combined with NGF in PC12 cells
- Effects observed at micromolar concentrations
- Mechanism appeared to involve activation of specific signaling pathways
A 2010 study in Food Science and Technology Research further explored the mechanism, suggesting PQQ activates the cAMP response element-binding protein (CREB) pathway, which regulates NGF gene expression. This provided a plausible biochemical explanation for the observed effects.
The Gap Between Cell Culture and Human Brains
Here's where we need to apply considerable caution. Cell culture studies, while valuable for understanding mechanisms, don't tell us whether oral PQQ supplementation actually increases NGF levels in human brains.
Several critical questions remain inadequately addressed:
Bioavailability: Does orally consumed PQQ reach the brain in sufficient concentrations? A 2016 pharmacokinetic study in humans by Harris et al. showed that PQQ is absorbed and detectable in blood after oral dosing, but brain penetration data remains limited.
Relevant concentrations: The concentrations used in cell studies (often 10-50 micromolar) may not reflect what's achievable in brain tissue through supplementation. A typical supplement dose of 10-20mg might produce blood levels far below what stimulated NGF in petri dishes.
Translation to living systems: The brain's regulatory environment is vastly more complex than isolated cells. Feedback mechanisms, competing pathways, and the blood-brain barrier all complicate extrapolation from in vitro findings.
No published human study has directly measured brain NGF levels before and after PQQ supplementation. This represents a significant gap in the evidence.
What Human Studies Actually Measured
Several human trials have examined PQQ's cognitive effects, but they've measured outcomes rather than the proposed NGF mechanism.
A 2016 randomized controlled trial by Itoh et al. published in Functional Foods in Health and Disease gave middle-aged and elderly participants 20mg PQQ daily for 12 weeks. Researchers reported improvements in cognitive function tests, particularly in attention and working memory measures. However, the study was small (41 participants) and didn't measure NGF levels.
Another Japanese study from 2012 in Journal of Clinical Biochemistry and Nutrition examined PQQ's effects on sleep quality and fatigue, finding modest improvements. Again, these functional outcomes can't confirm the NGF mechanism.
Human Trial Limitations
- Small sample sizes (typically under 50 participants)
- Short duration (8-12 weeks)
- No direct measurement of NGF or other neurotrophins
- Most studies conducted by researchers with industry connections
- Limited replication by independent groups
Alternative Mechanisms Worth Considering
Even if PQQ does produce cognitive benefits, NGF stimulation may not be the primary mechanism. PQQ has several other documented biological activities that could influence brain function:
Mitochondrial effects: PQQ appears to stimulate mitochondrial biogenesis through PGC-1α activation. Given the brain's enormous energy demands, improved mitochondrial function could enhance cognition independently of NGF.
Antioxidant activity: PQQ is a potent redox cofactor, cycling between oxidized and reduced forms thousands of times—far more than conventional antioxidants. This could protect neurons from oxidative stress.
Anti-inflammatory effects: Some research suggests PQQ may modulate inflammatory signaling, which could benefit brain health given inflammation's role in neurodegeneration.
These mechanisms aren't mutually exclusive, but they complicate the clean narrative that PQQ works primarily through NGF.
A Realistic Assessment
The honest summary: PQQ does stimulate NGF production in cell cultures, and this finding has been replicated. The mechanism involves plausible signaling pathways. However, we lack direct evidence that supplemental PQQ increases brain NGF in humans.
This doesn't mean PQQ is useless for cognitive health—the human trials, while limited, do suggest potential benefits. But attributing those benefits specifically to NGF enhancement is premature.
The supplement industry often collapses the distance between "stimulates X in cells" and "increases X in your brain." These are very different claims requiring different evidence.
Practical Considerations
For those considering PQQ supplementation:
Dosing in studies typically ranged from 10-20mg daily. PQQ appears well-tolerated at these levels, with no serious adverse effects reported in trials lasting up to 12 weeks.
The compound is found naturally in small amounts in various foods—kiwi, parsley, green peppers, and fermented soybeans contain notable quantities. However, dietary intake is typically measured in nanograms rather than the milligrams used in supplement research.
If you're interested in supporting nerve growth factor through lifestyle factors with stronger evidence, consider exercise (which reliably increases brain-derived neurotrophic factor, a related neurotrophin) and adequate sleep (both associated with neurotrophin regulation).
The Bottom Line
PQQ's NGF-stimulating effects in cell cultures are real and scientifically interesting. But the marketing claim that taking PQQ supplements will meaningfully increase NGF in your brain and thereby improve cognition outruns the available evidence.
The compound may indeed support cognitive function—early human trials are cautiously encouraging—but we can't yet confirm the mechanism. Better human research, including studies that directly measure neurotrophins, would help clarify whether PQQ's in vitro promise translates to meaningful brain effects in living humans.
Until then, approach the NGF narrative with appropriate skepticism while remaining open to PQQ's potential through other pathways.